Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41059669.
- Also identified by DOI 10.1002/hed.70045 and PMC identifier 12891758.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high-risk thyroid surgeries. Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005-2024). We identified 120 patients with a median follow-up of 4.6 years (range 0.02-16.38). Papillary thyroid cancer was most common (68%). The median number of tracheal rings resected was 4 (range 1-9). Seventeen (14%) patients had a new tracheostomy placed at the time of surgery, with 11 (9%) remaining trach-dependent at last follow-up. Twenty-six (22%) patients had a return to the operating room within 30 days, while 3 (3%) patients suffered perioperative mortality. The more common postoperative complications included tracheostomy tube placement (10%), hematoma (7%), and anastomotic air leak (6%). Median hospitalization was 6 days (range 2-67). Locoregional control (LRC) and overall survival (OS) were 79% and 77% at 5 years, respectively. Segmental tracheal resection for advanced thyroid cancer is technically complex and high-risk, but most patients stay recurrence-free 5 years post-surgery.
Medical subject headings
- Thyroid Neoplasms
- Trachea